Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00174876 | Aripiprazole as Augmentation for TRD | PHASE2 | COMPLETED | 20 | — | — | Jul 1, 2004 | May 1, 2005 | Sep 18, 2008 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| Drug Abilify | DRUG | - |
Inclusion Criteria: * Inclusion Criteria: males or females age 18 to 65 years, DSM-IV episode of Major Depression non-psychotic, ≥14 score on the 17-item HRSD, adequate trial with two antidepressants (see definition above of 'adequate trial'), ability to receive and give informed consent, if patien...